| P2093 | author name string | C H Markham | |
| | L J Treciokas | |
| | S G Diamond | |
| P2860 | cites work | Parkinsonism: onset, progression, and mortality | Q28259134 |
| | Levodopa's awakening effect on patients with Parkinsonism | Q33756468 |
| | Does levodopa alter depression and psychopathology in Parkinsonism patients? | Q33756784 |
| | Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system | Q34248307 |
| | The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia | Q34251567 |
| | PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA. | Q34256347 |
| | One to two year treatment of Parkinson's disease with levodopa | Q34769814 |
| | THE SUBCELLULAR LOCALIZATION OF DOPAMINE AND ACETYLCHOLINE IN THE DOG CAUDATE NUCLEUS. | Q35227489 |
| | An analysis of six patients with Parkinson's disease who have been unresponsive to L-dopa therapy | Q37091013 |
| | Psychiatric symptoms in Parkinsonism | Q39342331 |
| | Extra-blood-brain-barrier brain structures. | Q39968245 |
| | Dopamine (3-hydroxytyramine) and brain function | Q40035585 |
| | Personality (MMPI) and cognitive (WAIS) changes after levodopa treatment | Q42232393 |
| | Carbidopa in Parkinson disease and in nausea and vomiting of levodopa | Q42235880 |
| | The choreoathetoid movement disorder induced by levodopa | Q42239290 |
| | Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain | Q42438675 |
| | The connexions of the striatum and globus pallidus: synthesis and speculation. | Q42439040 |
| | Hyperactivity of Remaining Dopaminergic Neurones after Partial Destruction of the Nigro-striatal Dopaminergic System in the Rat | Q42439327 |
| | Striatonigral degeneration. Clinical-pathological correlations and response to stereotaxic surgery | Q42440947 |
| | ??? | Q64876266 |
| | ??? | Q64895765 |
| | ??? | Q64948832 |
| | ??? | Q64968189 |
| | ??? | Q67218795 |
| | Role of -aminobutyric acid (GABA) in the extrapyramidal motor system. 2. Some evidence for the existence of a type of GABA-rich strio-nigral neurons | Q42441959 |
| | DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS. | Q42449524 |
| | Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa). | Q43929731 |
| | Further study on pharmacological properties of the cerebellar-induced inhibition of Deiters neurones | Q44049863 |
| | Levodopa Therapy Effects on Natural History of Parkinsonism | Q44964825 |
| | Reduced glutamic-acid-decarboxylase activity of post-mortem brain in Huntington's chorea | Q45300694 |
| | Modification of Parkinsonism--chronic treatment with L-dopa | Q45300970 |
| | Use of L-dopa in the detection of presymptomatic Huntington's chorea | Q45302373 |
| | Analysis of the fine structure of the dopaminergic nigrostriatal projection by electron microscopic autoradiography | Q48617949 |
| | Effect of section of the strionigral fibers on dopamine turnover in the forebrain of the rat. | Q48621792 |
| | Striatonigral degeneration. Response to levodopa therapy with pathological and neurochemical correlation | Q48647425 |
| | L-Glutamic Acid Decarboxylase in Parkinson's Disease: Effect of L-Dopa Therapy | Q48650334 |
| | A quantitative investigation of the development of collateral reinnervation after partial deafferentation of the septal nuclei | Q48680473 |
| | Regeneration of central serotonin neurons after axonal degeneration induced by 5,6-dihydroxytryptamine | Q48681705 |
| | Effect of l-DOPA on brain acetylcholine and choline in rats | Q48698122 |
| | Evidence for regenerative axon sprouting of central catecholamine neurons in the rat mesencephalon following electrolytic lesions | Q48846869 |
| | The pathology of Parkinsonism. Part I. Some new observations and correlations | Q48859879 |
| | Gas chromatographic evaluation of the influence of oxotremorine upon the regional distribution of acetylcholine in rat brain | Q48880258 |
| | GABA and inhibition of Deiters' neurones | Q48894660 |
| | L-dopa in progressive supranuclear palsy | Q48902188 |
| | Neuronal plasticity in the septal nuclei of the adult rat | Q49021050 |
| | Intellectual impairment in Parkinson's syndrome | Q51110975 |
| | Neostriatal choline acetylase and cholinesterase following selective brain lesions. | Q51115444 |
| | Cerebral Catecholamines After Levodopa Therapy | Q51118191 |
| | Plastic changes in the adrenergic innervation of the rat septal area in response to denervation. | Q51119120 |
| | The site of termination of afferent fibres in the caudate nucleus. | Q51120863 |
| | The synaptic organization of the caudate nucleus. | Q51120868 |
| | The termination of fibres from the cerebral cortex and thalamus upon dendritic spines in the caudate nucleus: a study with the Golgi method. | Q51120870 |
| | The structure of the caudate nucleus of the cat: light and electron microscopy. | Q51120873 |
| | Blockage of caudate-evoked inhibition of neurons in the substantia nigra by picrotoxin. | Q51121353 |
| | Monosynaptic inhibition of neurons of the substantia nigra by caudato-nigral fibers. | Q51121355 |
| | REGIONAL DISTRIBUTION OF CIRCULATING BLOOD DURING SUBMERSION ASPHYXIA IN THE DUCK. | Q51271177 |
| | EXPERIMENTAL MANGANESE ENCEPHALOPATHY IN MONKEYS. A PRELIMINARY REPORT | Q51285238 |
| | An experimental study of the course and destination of fibers arising in the head of the caudate nucleus in the cat and monkey. | Q51307817 |
| | Occurrence and distribution of dopamine in brain and other tissues. | Q51316949 |
| | L-dopa in idiopathic parkinsonism. | Q52125293 |
| | Slowly absorbed L-dopa preparation in the treatment of parkinsonism | Q53904925 |
| | Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with Levodopa | Q55061662 |
| | L-dopa treatment failure: explanation and correction | Q55195310 |
| | Blood levels of FSH, LH, TSH, and GH in parkinsonian patients before and during L-dopa treatment | Q64917951 |
| | Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism. | Q67207616 |
| | L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism | Q67217791 |
| | [The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease.] | Q67222511 |
| | [Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome]. | Q67224420 |
| | [Nigro-striate and cerebello-nigro-striate degeneration. (Clinical uniqueness and pathological variability of presenile degeneration of the extrapyramidal rigidity type] | Q67226491 |
| | Undesirable prepubertal effects of levodopa | Q69588123 |
| | Administration of a peripheral decarboxylase inhibitor with L-dopa to depressed patients | Q70133434 |
| | Modification of chronic manganese poisoning. Treatment with L-dopa or 5-OH tryptophane | Q71120137 |
| | [The capillary enzyme barrier for DOPA at the level of some brain stem nuclei in the rat] | Q71492347 |
| | Chronic manganese poisoning. Clinical picture and manganese turnover | Q72332144 |
| | The occurrence, distribution and physiological role of catecholamines in the nervous system | Q78711372 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| | levodopa | Q300989 |
| P304 | page(s) | 188-206 | |
| P577 | publication date | 1974-09-01 | |
| P1433 | published in | Western Journal of Medicine | Q7476269 |
| P1476 | title | Parkinson's disease and levodopa. A five-year follow-up and review | |
| P478 | volume | 121 | |